These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 23884270

  • 21. Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
    Yamaguchi M, Hori M, Hiroshi N, Maruyama S.
    Thromb Res; 2017 Mar; 151():79-81. PubMed ID: 28167400
    [No Abstract] [Full Text] [Related]

  • 22. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
    Christmann M, Hansen M, Bergmann C, Schwabe D, Brand J, Schneider W.
    Pediatrics; 2014 Jun; 133(6):e1759-63. PubMed ID: 24843059
    [Abstract] [Full Text] [Related]

  • 23. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M.
    Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
    [Abstract] [Full Text] [Related]

  • 24. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
    Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G.
    Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717
    [Abstract] [Full Text] [Related]

  • 25. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM, Cugno M.
    Thromb Res; 2015 Nov 04; 136(5):851-4. PubMed ID: 26386489
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 04; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 27. Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3.
    Ferreira E, Oliveira N, Marques M, Francisco L, Santos A, Carreira A, Campos M.
    Nefrologia; 2016 Dec 04; 36(1):72-5. PubMed ID: 26541438
    [No Abstract] [Full Text] [Related]

  • 28. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 04; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 29. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
    Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B.
    Pediatrics; 2014 Jun 04; 133(6):e1764-8. PubMed ID: 24843055
    [Abstract] [Full Text] [Related]

  • 30. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
    Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A.
    Ren Fail; 2014 Aug 04; 36(7):1119-21. PubMed ID: 24828571
    [Abstract] [Full Text] [Related]

  • 31. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.
    Vilalta R, Lara E, Madrid A, Chocron S, Muñoz M, Casquero A, Nieto J.
    Pediatr Nephrol; 2012 Dec 04; 27(12):2323-6. PubMed ID: 22890512
    [Abstract] [Full Text] [Related]

  • 32. Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
    Ferri M, Zotta F, Donadelli R, Dossier C, Duneton C, El-Sissy C, Fremeau-Bacchi V, Kwon T, Quadri L, Pasini A, Sellier-Leclerc AL, Vivarelli M, Hogan J.
    Pediatr Nephrol; 2024 Nov 04; 39(11):3263-3269. PubMed ID: 38632123
    [Abstract] [Full Text] [Related]

  • 33. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 04; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 34. Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.
    Belingheri M, Possenti I, Tel F, Paglialonga F, Testa S, Salardi S, Ardissino G.
    Pediatrics; 2014 Jun 04; 133(6):e1769-71. PubMed ID: 24843058
    [Abstract] [Full Text] [Related]

  • 35. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
    Ranch D, Crowther B, Arar M, Assanasen C.
    Pediatr Transplant; 2014 Sep 04; 18(6):E185-9. PubMed ID: 24931815
    [Abstract] [Full Text] [Related]

  • 36. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S.
    Pediatr Nephrol; 2011 Aug 04; 26(8):1325-9. PubMed ID: 21556717
    [Abstract] [Full Text] [Related]

  • 37. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.
    Hackl A, Ehren R, Kirschfink M, Zipfel PF, Beck BB, Weber LT, Habbig S.
    Pediatr Nephrol; 2017 Jun 04; 32(6):1081-1087. PubMed ID: 28220235
    [Abstract] [Full Text] [Related]

  • 38. Hemolytic uremic syndrome with multiple organ involvement secondary to complement factor H p.Arg1215X mutation.
    Yeşilbaş O, Şevketoğlu E, Petmezci MT, Kıhtır HS, Benzer M, Berdeli A.
    Turk J Pediatr; 2017 Jun 04; 59(5):576-580. PubMed ID: 29745120
    [Abstract] [Full Text] [Related]

  • 39. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U, Matar RB, Rotz SJ.
    Pediatr Blood Cancer; 2019 Nov 04; 66(11):e27913. PubMed ID: 31286658
    [Abstract] [Full Text] [Related]

  • 40. Pregnancy-associated atypical hemolytic uremic syndrome. Case report.
    Barrera-Hoffmann C, Mariaca-Ortíz Y, Ruiz-Villa JG, Cuevas-Cruz LE, López-Mendoza MDR, Briones-Garduño JC.
    J Obstet Gynaecol Res; 2024 Jul 04; 50(7):1268-1272. PubMed ID: 38720638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.